CA3215373A1 - Solid forms of (r)-oxybutynin d-malate - Google Patents
Solid forms of (r)-oxybutynin d-malate Download PDFInfo
- Publication number
- CA3215373A1 CA3215373A1 CA3215373A CA3215373A CA3215373A1 CA 3215373 A1 CA3215373 A1 CA 3215373A1 CA 3215373 A CA3215373 A CA 3215373A CA 3215373 A CA3215373 A CA 3215373A CA 3215373 A1 CA3215373 A1 CA 3215373A1
- Authority
- CA
- Canada
- Prior art keywords
- oxybutynin
- crystalline
- malate
- salt
- peaks
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C219/00—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton
- C07C219/02—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton
- C07C219/20—Compounds containing amino and esterified hydroxy groups bound to the same carbon skeleton having esterified hydroxy groups and amino groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/216—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acids having aromatic rings, e.g. benactizyne, clofibrate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
- A61K31/222—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin with compounds having aromatic groups, e.g. dipivefrine, ibopamine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C221/00—Preparation of compounds containing amino groups and doubly-bound oxygen atoms bound to the same carbon skeleton
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C51/00—Preparation of carboxylic acids or their salts, halides or anhydrides
- C07C51/42—Separation; Purification; Stabilisation; Use of additives
- C07C51/43—Separation; Purification; Stabilisation; Use of additives by change of the physical state, e.g. crystallisation
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/235—Saturated compounds containing more than one carboxyl group
- C07C59/245—Saturated compounds containing more than one carboxyl group containing hydroxy or O-metal groups
- C07C59/255—Tartaric acid
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Emergency Medicine (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pulmonology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Crystallography & Structural Chemistry (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| USPCT/US2021/030571 | 2021-05-04 | ||
| PCT/US2021/030571 WO2021226020A1 (en) | 2020-05-05 | 2021-05-04 | Polymorphic forms of (r)-oxybutynin hydrochloride |
| US202163248684P | 2021-09-27 | 2021-09-27 | |
| US63/248,684 | 2021-09-27 | ||
| PCT/US2022/027573 WO2022235726A1 (en) | 2021-05-04 | 2022-05-04 | Solid forms of (r)-oxybutynin d-malate |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CA3215373A1 true CA3215373A1 (en) | 2022-11-10 |
Family
ID=81654984
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CA3215373A Pending CA3215373A1 (en) | 2021-05-04 | 2022-05-04 | Solid forms of (r)-oxybutynin d-malate |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US20240217918A1 (enExample) |
| EP (1) | EP4334281A1 (enExample) |
| JP (1) | JP2024518370A (enExample) |
| KR (1) | KR20240004600A (enExample) |
| AU (1) | AU2022270639A1 (enExample) |
| CA (1) | CA3215373A1 (enExample) |
| WO (1) | WO2022235726A1 (enExample) |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4522811A (en) | 1982-07-08 | 1985-06-11 | Syntex (U.S.A.) Inc. | Serial injection of muramyldipeptides and liposomes enhances the anti-infective activity of muramyldipeptides |
| WO2009122429A2 (en) * | 2008-02-04 | 2009-10-08 | Matrix Laboratories Limited | Crystalline oxybutynin and process for preparing the same |
| CN104370760B (zh) * | 2013-11-29 | 2016-06-01 | 江苏汉邦科技有限公司 | 模拟移动床色谱拆分奥昔布宁对映体的方法 |
| KR102874891B1 (ko) | 2018-01-30 | 2025-10-21 | 애프니메드, 인코포레이티드 (델라웨어) | 수면 무호흡증을 치료하기 위한 방법 및 조성물 |
-
2022
- 2022-05-04 EP EP22723937.3A patent/EP4334281A1/en active Pending
- 2022-05-04 WO PCT/US2022/027573 patent/WO2022235726A1/en not_active Ceased
- 2022-05-04 KR KR1020237040419A patent/KR20240004600A/ko active Pending
- 2022-05-04 CA CA3215373A patent/CA3215373A1/en active Pending
- 2022-05-04 JP JP2023567201A patent/JP2024518370A/ja active Pending
- 2022-05-04 US US18/289,126 patent/US20240217918A1/en active Pending
- 2022-05-04 AU AU2022270639A patent/AU2022270639A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| AU2022270639A1 (en) | 2023-12-14 |
| JP2024518370A (ja) | 2024-05-01 |
| US20240217918A1 (en) | 2024-07-04 |
| KR20240004600A (ko) | 2024-01-11 |
| EP4334281A1 (en) | 2024-03-13 |
| WO2022235726A1 (en) | 2022-11-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2527768T3 (es) | Sales cristalinas de sitagliptina | |
| US6242460B1 (en) | Zolpidem salt forms | |
| AU2007284851B2 (en) | Crystalline antifungal compounds | |
| JP2025094218A (ja) | Jak2阻害剤の結晶形態 | |
| US20240217944A1 (en) | Salt forms of r-mdma and methods using the same | |
| JP5336509B2 (ja) | (r)−3−フルオロフェニル−3,4,5−トリフルオロベンジルカルバミン酸1−アザビシクロ[2.2.2]オクト−3−イルエステルの安定な結晶性塩 | |
| JP2019512542A (ja) | 結晶塩形態 | |
| HUP0001878A2 (hu) | (R)-3-(N,N-diciklobutil-amino)-8-fluor-3,4-dihidro-2H-1-benzopirán-5-karboxamid-hidrogén tartarát, eljárás előállítására és ezt tartalmazó gyógyszerkészítmények | |
| US20240217918A1 (en) | Solid forms of (r)-oxybutynin d-malate | |
| US7429679B2 (en) | Sulphonic acid salt of sibutramine | |
| JP2008526836A (ja) | シブトラミンの無機酸塩 | |
| EP1451166B1 (en) | Citric acid salt of a therapeutic compound and pharmaceutical compositions thereof | |
| CN117396460A (zh) | (r)-奥昔布宁d-苹果酸盐的固体形式 | |
| WO2021226020A1 (en) | Polymorphic forms of (r)-oxybutynin hydrochloride | |
| US12448347B2 (en) | Polymorphic forms of (R)-oxybutynin hydrochloride | |
| EA051728B1 (ru) | Полиморфные формы (r)-оксибутинина гидрохлорида | |
| EP3210975A1 (en) | Cocrystals of lorcaserin | |
| HK1178519B (en) | Metaxalone cocrystals | |
| HK1178519A1 (zh) | 美他沙酮共晶体 | |
| MX2011002728A (es) | Nueva sal de derivado de morfolina. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 3RD ANNIV.) - STANDARD Year of fee payment: 3 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20250407 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20250407 |
|
| MFA | Maintenance fee for application paid |
Free format text: FEE DESCRIPTION TEXT: MF (APPLICATION, 4TH ANNIV.) - STANDARD Year of fee payment: 4 |
|
| U00 | Fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED Effective date: 20260401 |
|
| U11 | Full renewal or maintenance fee paid |
Free format text: ST27 STATUS EVENT CODE: A-1-1-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL Effective date: 20260401 |
|
| D11 | Substantive examination requested |
Free format text: ST27 STATUS EVENT CODE: A-1-1-D10-D11-D117 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: REQUEST FOR EXAMINATION RECEIVED Effective date: 20260423 |
|
| W00 | Other event occurred |
Free format text: ST27 STATUS EVENT CODE: A-1-1-W10-W00-W111 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: CORRESPONDENT DETERMINED COMPLIANT Effective date: 20260423 |